Cargando…
Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease
BACKGROUND: Pompe disease is an autosomal recessive metabolic disorder caused by the deficiency of the lysosomal enzyme acid α-glucosidase. This deficiency leads to glycogen accumulation in the lysosomes of muscle tissue causing progressive muscular weakness particularly of the respiratory system. E...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471388/ https://www.ncbi.nlm.nih.gov/pubmed/28649546 http://dx.doi.org/10.1016/j.ymgmr.2015.09.007 |
_version_ | 1783243940186554368 |
---|---|
author | Mitja, Jevnikar Metka, Kodric Fabiana, Cantarutti Cifaldi, Rossella Longo, Cinzia Rossana, Della Porta Bruno, Bembi Marco, Confalonieri |
author_facet | Mitja, Jevnikar Metka, Kodric Fabiana, Cantarutti Cifaldi, Rossella Longo, Cinzia Rossana, Della Porta Bruno, Bembi Marco, Confalonieri |
author_sort | Mitja, Jevnikar |
collection | PubMed |
description | BACKGROUND: Pompe disease is an autosomal recessive metabolic disorder caused by the deficiency of the lysosomal enzyme acid α-glucosidase. This deficiency leads to glycogen accumulation in the lysosomes of muscle tissue causing progressive muscular weakness particularly of the respiratory system. Enzyme replacement therapy (ERT) has demonstrated efficacy in slowing down disease progression in infants. Despite the large number of studies describing the effects of physical training in juvenile and adult late onset Pompe disease (LOPD). There are very few reports that analyze the benefits of respiratory muscle rehabilitation or training. METHODS: The effectiveness of respiratory muscle training was investigated using a specific appliance with adjustable resistance (Threshold). The primary endpoint was effect on respiratory muscular strength by measurements of MIP and MEP. Eight late-onset Pompe patients (aged 13 to 58 years; 4 female, 4 male) with respiratory muscle deficiency on functional respiratory tests were studied. All patients received ERT at the dosage of 20 mg/kg/every 2 weeks and underwent training with Threshold at specified pressures for 24 months. RESULTS: A significant increase in MIP was observed during the follow-up of 24 month: 39.6 cm H(2)O (+ 25.0%) at month 3; 39.5 cm H(2)O (+ 24.9%) at month 6; 39.1 cm H(2)O (+ 23.7%) at month 9; 37.3 cm H(2)O (+ 18.2%) at month 12; and 37.3 cm H(2)O (+ 17.8%) at month 24. Median MEP values also showed a significant increase during the first 9 months: 29.8 cm H(2)O, (+ 14.3%) at month 3; 31.0 cm H(2)O (+ 18.6) at month 6; and 29.5 cm H(2)O (+ 12.9) at month 9. MEP was then shown to be decreased at months 12 and 24; median MEP was 27.2 cm H(2)O (+ 4.3%) at 12 months and 26.6 cm H(2)O (+ 1.9%) at 24 months. The FVC remain stable throughout the study. CONCLUSION: An increase in respiratory muscular strength was demonstrated with Threshold training when used in combination with ERT. |
format | Online Article Text |
id | pubmed-5471388 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-54713882017-06-23 Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease Mitja, Jevnikar Metka, Kodric Fabiana, Cantarutti Cifaldi, Rossella Longo, Cinzia Rossana, Della Porta Bruno, Bembi Marco, Confalonieri Mol Genet Metab Rep Research Paper BACKGROUND: Pompe disease is an autosomal recessive metabolic disorder caused by the deficiency of the lysosomal enzyme acid α-glucosidase. This deficiency leads to glycogen accumulation in the lysosomes of muscle tissue causing progressive muscular weakness particularly of the respiratory system. Enzyme replacement therapy (ERT) has demonstrated efficacy in slowing down disease progression in infants. Despite the large number of studies describing the effects of physical training in juvenile and adult late onset Pompe disease (LOPD). There are very few reports that analyze the benefits of respiratory muscle rehabilitation or training. METHODS: The effectiveness of respiratory muscle training was investigated using a specific appliance with adjustable resistance (Threshold). The primary endpoint was effect on respiratory muscular strength by measurements of MIP and MEP. Eight late-onset Pompe patients (aged 13 to 58 years; 4 female, 4 male) with respiratory muscle deficiency on functional respiratory tests were studied. All patients received ERT at the dosage of 20 mg/kg/every 2 weeks and underwent training with Threshold at specified pressures for 24 months. RESULTS: A significant increase in MIP was observed during the follow-up of 24 month: 39.6 cm H(2)O (+ 25.0%) at month 3; 39.5 cm H(2)O (+ 24.9%) at month 6; 39.1 cm H(2)O (+ 23.7%) at month 9; 37.3 cm H(2)O (+ 18.2%) at month 12; and 37.3 cm H(2)O (+ 17.8%) at month 24. Median MEP values also showed a significant increase during the first 9 months: 29.8 cm H(2)O, (+ 14.3%) at month 3; 31.0 cm H(2)O (+ 18.6) at month 6; and 29.5 cm H(2)O (+ 12.9) at month 9. MEP was then shown to be decreased at months 12 and 24; median MEP was 27.2 cm H(2)O (+ 4.3%) at 12 months and 26.6 cm H(2)O (+ 1.9%) at 24 months. The FVC remain stable throughout the study. CONCLUSION: An increase in respiratory muscular strength was demonstrated with Threshold training when used in combination with ERT. Elsevier 2015-10-29 /pmc/articles/PMC5471388/ /pubmed/28649546 http://dx.doi.org/10.1016/j.ymgmr.2015.09.007 Text en © 2015 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Paper Mitja, Jevnikar Metka, Kodric Fabiana, Cantarutti Cifaldi, Rossella Longo, Cinzia Rossana, Della Porta Bruno, Bembi Marco, Confalonieri Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease |
title | Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease |
title_full | Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease |
title_fullStr | Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease |
title_full_unstemmed | Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease |
title_short | Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease |
title_sort | respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset pompe disease |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471388/ https://www.ncbi.nlm.nih.gov/pubmed/28649546 http://dx.doi.org/10.1016/j.ymgmr.2015.09.007 |
work_keys_str_mv | AT mitjajevnikar respiratorymuscletrainingwithenzymereplacementtherapyimprovesmusclestrengthinlateonsetpompedisease AT metkakodric respiratorymuscletrainingwithenzymereplacementtherapyimprovesmusclestrengthinlateonsetpompedisease AT fabianacantarutti respiratorymuscletrainingwithenzymereplacementtherapyimprovesmusclestrengthinlateonsetpompedisease AT cifaldirossella respiratorymuscletrainingwithenzymereplacementtherapyimprovesmusclestrengthinlateonsetpompedisease AT longocinzia respiratorymuscletrainingwithenzymereplacementtherapyimprovesmusclestrengthinlateonsetpompedisease AT rossanadellaporta respiratorymuscletrainingwithenzymereplacementtherapyimprovesmusclestrengthinlateonsetpompedisease AT brunobembi respiratorymuscletrainingwithenzymereplacementtherapyimprovesmusclestrengthinlateonsetpompedisease AT marcoconfalonieri respiratorymuscletrainingwithenzymereplacementtherapyimprovesmusclestrengthinlateonsetpompedisease |